KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to -$49.5 million.

  • Teladoc Health's Net Income towards Common Stockholders fell 4868.75% to -$49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$223.5 million, marking a year-over-year increase of 7724.02%. This contributed to the annual value of -$1.0 billion for FY2024, which is 35435.14% down from last year.
  • According to the latest figures from Q3 2025, Teladoc Health's Net Income towards Common Stockholders is -$49.5 million, which was down 4868.75% from -$32.6 million recorded in Q2 2025.
  • Teladoc Health's Net Income towards Common Stockholders' 5-year high stood at -$11.0 million during Q4 2021, with a 5-year trough of -$6.7 billion in Q1 2022.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$73.4 million (2022), whereas its average is -$815.0 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 3465417.31% in 2022, then soared by 9924.06% in 2023.
  • Over the past 5 years, Teladoc Health's Net Income towards Common Stockholders (Quarter) stood at -$11.0 million in 2021, then tumbled by 34654.17% to -$3.8 billion in 2022, then surged by 99.24% to -$28.9 million in 2023, then crashed by 67.14% to -$48.4 million in 2024, then fell by 2.37% to -$49.5 million in 2025.
  • Its Net Income towards Common Stockholders was -$49.5 million in Q3 2025, compared to -$32.6 million in Q2 2025 and -$93.0 million in Q1 2025.